Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease

American Journal of Cardiology

Volumn 109, Issue 1, 2012, Pages 42-46

  Emoto, Takuo ^a   Sawada, Takahiro ^a   Hashimoto, Megumi ^a   Kageyama, Hiroko ^a   Terashita, Daisuke ^a   Mizoguchi, Taiji ^a   Mizuguchi, Takao ^a   Motodi, Yoshiki ^a   Iwasaki, Masamichi ^a   Taira, Kazuki ^a   Okamoto, Hiroshi ^a   Matsuo, Yosuke ^a   Kim, Sushi Ku ^a   Takarada, Akira ^a   Yokoyama, Mitsuhiro ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; MIGLITOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SULFONYLUREA; VOGLIBOSE;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIGESTIVE SYSTEM DISEASE; DILATATION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASCULAR ENDOTHELIUM;

1-DEOXYNOJIRIMYCIN; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLUCOSIDASES; BLOOD GLUCOSE; BRACHIAL ARTERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 83555168228     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.08.005     Document Type: Article

References (18)

1. L.J. Scott, D.M. Spencer Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus Drugs 59 2000 521 549 (Pubitemid 30213863)
2. M. Hiki, K. Shimada, T. Kiyanagi, K. Fukao, K. Hirose, H. Ohsaka Single administration of α-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease Juntendo University Trial: Effects of Miglitol on Endothelial Vascular Reactivity in Type 2 Diabetic Patients With Coronary Heart Disease (J-MACH) Circ J 2010 1471 1478
3. T. Suwa, A. Ohta, T. Matsui, R. Koganei, H. Kato, T. Kawata Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM) Endocr J 57 2010 135 140
4. A. Ceriello, S. Colagiuri International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations Diabet Med 25 2008 1151 1156
5. G. Patti, V. Pasceri, R. Melfi, C. Goffredo, M. Chello, A. D'Ambrosio Impaired flow-mediated dilatation and risk of restenosis in patients undergoing coronary stent implantation Circulation 111 2005 70 75 (Pubitemid 40070846)
6. J.H. O'Keefe, D.S. Bell Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor Am J Cardiol 100 2007 899 904 (Pubitemid 47268287)
7. D.S. Bell, J.H. O'Keefe, P. Jellinger Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events? Endocr Pract 14 2008 112 124
8. P.B. Mellen, V. Bittner, D.M. Herrington Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women Diabet Med 24 2007 1156 1159 (Pubitemid 47437879)
9. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOPNIDDM trial JAMA 290 2003 486 494 (Pubitemid 37430502)
10. M. Hanefeld, M. Cagatay, T. Petrowitsch, D. Neuser, D. Petzinna, M. Rupp Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies Eur Heart J 25 2004 10 16 (Pubitemid 38055587)
11. D.S. Celermajer, K.E. Sorensen, V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
12. K. Esposito, M. Ciotola, D. Carleo, B. Schisano, L. Sardelli, D.D. Tommaso Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes J Clin Endocrinol Metab 93 2008 1345 1350 (Pubitemid 351519731)
13. American Diabetes Association Postprandial blood glucose (consensus statement) Diabetes Care 24 2001 775 778
14. K.M. Dungan, J.B. Buse, J. Largay, M.M. Kelly, E.A. Button, S. Kato 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes Diabetes Care 29 2006 1214 1219 (Pubitemid 44125912)
15. M. Dworacka, E. Wender-Ozegowska, H. Winiarska, M. Borowska, A. Zawiejska, M. Pietryga Plasma anhydro-D-glucitol (1,5-AG) as an indicator of hyperglycemic excursions in pregnant women with diabetes Diabetic Med 23 2006 171 175
16. M. Ohira, K. Endo, T. Oyama Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70 Metabolism 60 2011 78 85
17. M. Arakawa, C. Ebato, T. Mita, Y. Fujitani, T. Shimizu, H. Watada Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects Metabolism 57 2008 1299 1306
18. J.Q. Purnell, C. Weyer Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity Treat Endocrinol 2 2003 33 47 (Pubitemid 37051601)